• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Quest Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92906.0
  • ISIN : INE0TNW01017
111.25 6 (5.20%)
  • As on 27 Jul 2025 (EOD)

  • Today’s Low

    108.65

  • Today’s High

    126.90

  • Open

    126.90

  • Perv Close

    105.75

  • 52W Low

    75.15

  • 52W High

    160.00

Key Indicators

  • P/E(TTM)

    11.26

  • Mar.Cap (₹Cr.)

    182.31

  • Div & Yield %

    0.00

  • Book Value(₹)

    49.92

  • Debt-Equity Ratio

    5.20

  • AGM Date

    25-Jul-2025

  • EPS

    9.88

  • P/E Ratio

    11.26

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    182.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.39

  • BV (₹)

    49.90

  • Sales( ₹ in Cr.)

    103.91

  • NP (in Cr.)

    13.57

  • NP Var(%)

    34.0

  • Div%

    0.0

  • CPS (₹)

    8.70

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    182.31

  • 52 Week High

    160.00

  • 52 Week Low

    75.15

  • Price BSE

    0.0

  • Price NSE

    111.00

  • Market Capital( in Cr.)

    182.31

  • P/C Ratio

    12.80

  • P/E Ratio

    13.40

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 82.56 61.64 59.48 30.36 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 82.56 61.64 59.48 30.36 - -
Other Income 0.23 0.23 0.06 0.07 - -
Stock Adjustments 0.04 -0.08 -0.22 -0.03 - -
Total Income 82.83 61.79 59.32 30.40 - -
EXPENDITURE :            
Raw Materials 52.29 41.72 44.27 24.43 - -
Power and Fuel Cost 0.87 0.79 0.58 0.40 - -
Employee Cost 3.64 2.80 3.04 2.11 - -
Other Manufacturing Expenses 0.30 0.30 0.30 0.23 - -
Selling and Administration Expenses 7.02 5.32 3.16 1.39 - -
Miscellaneous Expenses 2.92 2.75 1.44 0.35 - -
Employee Benefit Expenses 3.64 2.80 3.04 2.11 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 67.04 53.68 52.79 28.91 - -
Operating Profit 15.79 8.11 6.53 1.49 - -
Interest 0.78 0.58 0.30 0.31 - -
Gross Profit 15.01 7.53 6.23 1.18 - -
Depreciation 0.57 0.55 0.46 0.39 - -
Profit Before Tax 14.44 6.98 5.77 0.79 - -
Current Tax 4.21 1.79 1.55 0.15 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.15 0.15 0.11 -0.01 - -
Reported Net Profit 10.09 5.04 4.11 0.66 - -
Extraordinary Items 0.00 0.00 -0.02 0.00 - -
Adjusted Net Profit 10.09 5.04 4.13 0.66 - -
Adjustment below Net Profit -8.11 0.00 0.00 0.00 - -
P & L Balance brought forward 12.42 7.38 3.21 2.56 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 14.41 12.42 7.32 3.21 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 8.46 46.77 38.05 6.07 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 23.99 139.97 92.64 54.58 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    66.21%

  • Public Share Holding

    33.79%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 10,850,500 66.21 10,850,500 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,850,500 66.21 10,850,500 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 156,000 0.95 0 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 12,000 0.07 12,000 1
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 326,400 1.99 326,400 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 494,400 3.02 338,400 7
2] Non Institution
Bodies Corporate 480,000 2.93 480,000 18
Clearing Members 271,200 1.66 271,200 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 112,800 0.69 112,800 30
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 169,200 1.03 169,200 53
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,980,550 12.09 1,980,550 30
Individuals holding nominal share capital up to Rs. 1 lakh 2,009,350 12.26 2,009,350 858
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 19,200 0.12 19,200 1
Sub Total 5,042,300 30.77 5,042,300 991
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,387,200 100.00 16,231,200 1,001

Company Background

Quest Laboratories LtdPharmaceuticals - Indian - Formulations

  • Quest Laboratories Ltd
  • BSE Code : 92906.0
  • ISIN : INE0TNW01017

  • Incorporation Year

    1998

  • Registered Office

    Plot # 45 Sector III
    Pithampur, Dhar,
    Madhya Pradesh-454775

  • Telephone

    0729 2292 374

  • FAX

  • Chairman

    Mr Anil Kumar Sabarwal

  • Managing Director

    Mr Anil Kumar Sabarwal

  • Company Secretary

  • Auditor

    Shyam S. Gupta & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Quest Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Quest Laborato. 111.25 82.79 82.56 11.26 57.51
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10